Tandem Diabetes Care (TNDM) Net Shares Issued and Repurchased (2013 - 2019)
Tandem Diabetes Care's (TNDM) quarterly Net Shares Issued and Repurchased came in at $1.3 million in Q1 2019, down 72.14% quarter-over-quarter from $4.7 million in Q4 2018.
Analysis
Tandem Diabetes Care (TNDM) Net Shares Issued and Repurchased (2013 - 2019) Analysis & Trends
Tandem Diabetes Care (TNDM) has reported Net Shares Issued and Repurchased for 7 consecutive years, with $1.3 million the latest figure, recorded in Q1 2019.
- For the quarter ending Q1 2019, Net Shares Issued and Repurchased changed N/A year-over-year to $1.3 million; the trailing twelve-month figure through Mar 2019 stood at $1.3 million (changed N/A YoY), and the FY2018 full-year result was $4.7 million, up 669.18% from the prior year.
- Net Shares Issued and Repurchased declined to $1.3 million in Q1 2019 per TNDM's latest filing, from $4.7 million in the prior quarter.
- Across five years, Net Shares Issued and Repurchased topped out at $4.7 million in Q4 2018 and bottomed at $316316.0 in Q4 2016.
- Historically, Net Shares Issued and Repurchased has averaged $1.9 million across 5 years, with a median of $1.2 million in 2015.
- The sharpest annual moves came in 2016 and 2018: Net Shares Issued and Repurchased plunged 73.09% in 2016, then soared 669.18% in 2018.
- Over 5 years, Net Shares Issued and Repurchased stood at $1.2 million in 2015, then slumped by 73.09% to $316316.0 in 2016, then jumped by 94.45% to $615067.0 in 2017, then jumped by 669.18% to $4.7 million in 2018, then tumbled by 72.14% to $1.3 million in 2019.
- According to Business Quant data, Net Shares Issued and Repurchased over the past three periods registered $1.3 million, $4.7 million, and $3.3 million for Q1 2019, Q4 2018, and Q2 2018 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Shares Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | - |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | - |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | - |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | - |
| 10 | Tandem Diabetes Care | 1.26 Bn | 804.14 Mn | 144.78 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2019 | 1.32 Mn |
| Dec 31, 2018 | 4.73 Mn |
| Jun 30, 2018 | 3.34 Mn |
| Dec 31, 2017 | 615,067.00 |
| Dec 31, 2016 | 316,316.00 |
| Dec 31, 2015 | 1.18 Mn |
| Dec 31, 2014 | 760,639.00 |
| Dec 31, 2013 | 4.43 Mn |